Surgeon volume and 30 day mortality for brain tumours in England

Background:There is evidence that surgeons who perform more operations have better outcomes. However, in patients with brain tumours, all of the evidence comes from the USA.Methods:We examined all English patients with an intracranial neoplasm who had an intracranial resection in 2008–2010. We included surgeons who performed at least six operations over 3 years, and at least one operation in the first and last 6 months of the period.Results:The analysis data set comprised 9194 operations, 163 consultant neurosurgeons and 30 centres. Individual surgeon volumes varied widely (7–272; median=46). 72% of operations were on the brain, and 30 day mortality was 3%. A doubling of surgeon load was associated with a 20% relative reduction in mortality. Thirty day mortality varied between centres (0·95–8·62%) but was not related to centre workload.Conclusions:Individual surgeon volumes correlated with patient 30 day mortality. Centres and surgeons in England are busier than surgeons and centres in the USA. There is no relationship between centre volume and 30 day mortality in England. Services in the UK appear to be adequately arranged at a centre level, but would benefit from further surgeon sub-specialisation.

[1]  W. Curry,et al.  Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care. , 2005, Neuro-oncology.

[2]  R. Mirimanoff,et al.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.

[3]  D. Long,et al.  Outcome and Cost of Craniotomy Performed to Treat Tumors in Regional Academic Referral Centers , 2003, Neurosurgery.

[4]  J. Feinglass,et al.  Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Berger,et al.  Surgery for primary supratentorial brain tumors in the United States, 2000-2009: effect of provider and hospital caseload on complication rates. , 2015, Journal of neurosurgery.

[6]  John A. Cowan,et al.  The Impact of Provider Volume on Mortality after Intracranial Tumor Resection , 2003, Neurosurgery.

[7]  [Volume and health outcomes: an overview of systematic reviews]. , 2005, Epidemiologia e prevenzione.

[8]  J. Dimick,et al.  The impact of provider volume on mortality after intracranial tumor resection. , 2003 .

[9]  C. Begg,et al.  The Effect of Clustering of Outcomes on the Association of Procedure Volume and Surgical Outcomes , 2003, Annals of Internal Medicine.

[10]  Walter Stummer,et al.  Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion , 2011, Acta Neurochirurgica.

[11]  A. Pierro,et al.  A systematic review of the impact of volume of surgery and specialization on patient outcome , 2007, The British journal of surgery.

[12]  N. Bleehen,et al.  A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. , 1991, British Journal of Cancer.

[13]  A. Klibanski,et al.  Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume. , 2003, The Journal of clinical endocrinology and metabolism.

[14]  N G Burnet,et al.  Years of life lost (YLL) from cancer is an important measure of population burden – and should be considered when allocating research funds , 2005, British Journal of Cancer.